PCNA and breast carcinoma: Here, we extend these findings by demonstrating that treatment of human metastatic breast cancer cells with a Nodal blocking antibody decreases Nodal expression levels and Smad-2 phosphorylation and reduces cell proliferation and increases apoptosis by reducing cellular levels of pHH3, PCNA and BCL2α.